Premium Nahrungsergänzungsmittel | artgerecht

Bile Duct Cancer: Causes, Symptoms & Treatment

Bile duct cancer (cholangiocarcinoma) is a malignant tumor of the bile ducts. It often grows slowly, is frequently diagnosed late, and requires specialized treatment.

Regular tips about health Regular tips about health

Things worth knowing about "Bile duct cancer"

Bile duct cancer (cholangiocarcinoma) is a malignant tumor of the bile ducts. It often grows slowly, is frequently diagnosed late, and requires specialized treatment.

What is Bile Duct Cancer?

Bile duct cancer, medically known as cholangiocarcinoma, is a malignant tumor that originates from the cells lining the bile ducts. The bile ducts are tube-like structures that carry bile, produced by the liver, into the small intestine to aid in the digestion of fats. Cholangiocarcinoma is a rare but aggressive cancer and is frequently diagnosed only at an advanced stage.

Depending on the location of the tumor, three main types are distinguished:

Intrahepatic cholangiocarcinoma: The tumor is located within the liver.
Perihilar cholangiocarcinoma (Klatskin tumor): The tumor arises at the junction of the left and right hepatic bile ducts.
Distal cholangiocarcinoma: The tumor is found in the lower portion of the bile duct, near the small intestine.

Causes and Risk Factors

The exact causes of bile duct cancer are not fully understood. However, several factors are known to increase the risk:

Primary sclerosing cholangitis (PSC): A chronic inflammation and scarring of the bile ducts is a major risk factor.
Chronic liver inflammation: Hepatitis B or C infections and liver cirrhosis increase the risk of developing bile duct cancer.
Gallstones: Long-standing gallstone disease can irritate the bile duct wall.
Liver parasites: In Southeast Asia, infection with liver flukes (e.g., Opisthorchis viverrini) significantly increases the risk.
Congenital bile duct abnormalities: For example, choledochal cysts.
Toxic substances: Exposure to certain chemicals such as thorotrast.
Age and sex: The disease is more common in older adults (over 60 years) and affects men slightly more often than women.

Symptoms

In the early stages, bile duct cancer typically causes no or only non-specific symptoms, making early diagnosis difficult. As the tumor grows, the following symptoms may develop:

Jaundice (icterus): Yellowing of the skin and the whites of the eyes due to bile buildup.
Dark urine and pale stools: Signs of impaired bile drainage.
Itching (pruritus): Caused by bile acids accumulating in the skin.
Upper abdominal pain: A dull ache in the upper right abdomen.
Weight loss and loss of appetite: Common accompanying symptoms in cancer.
Fatigue and general malaise.
Fever: In cases of additional bile duct infection (cholangitis).

Diagnosis

Diagnosing bile duct cancer requires a combination of different examinations:

Blood tests: Elevated liver enzymes (e.g., bilirubin, alkaline phosphatase, GGT) and the tumor marker CA 19-9 can provide important clues.
Imaging procedures: Ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and MRCP (magnetic resonance cholangiopancreatography) are key diagnostic tools for visualizing the bile ducts.
Endoscopic procedures: ERCP (endoscopic retrograde cholangiopancreatography) allows direct assessment of the bile ducts and tissue sampling.
Biopsy: Histological examination of tissue samples definitively confirms the diagnosis.
PET-CT: Used to assess potential metastatic spread.

Treatment

The choice of treatment depends on the stage of the disease, the exact location of the tumor, and the overall health of the patient.

Surgery

Surgical removal of the tumor is the only potentially curative option. Depending on tumor location, this may involve partial liver resection, removal of the bile duct, or in select cases a liver transplantation. Unfortunately, curative surgery is often no longer possible at the time of diagnosis.

Chemotherapy

The standard chemotherapy regimen for cholangiocarcinoma is based on the combination of gemcitabine and cisplatin, used particularly for advanced or inoperable tumors. Newer combinations, for example with durvalumab (an immune checkpoint inhibitor), have improved treatment outcomes.

Targeted Therapies

In some patients, specific gene mutations (e.g., IDH1/IDH2 mutations, FGFR2 fusions) can be identified, for which targeted drugs (e.g., ivosidenib, pemigatinib) have been approved.

Radiation Therapy and Supportive Measures

Radiation therapy can be used for local tumor control. To relieve bile duct obstruction, biliary stent placement (endoscopic or percutaneous) is frequently performed to restore bile flow and relieve symptoms such as jaundice and itching.

Prognosis

The overall prognosis for bile duct cancer is serious. The five-year survival rate for patients who undergo surgery ranges from approximately 20 to 40 % depending on the stage, and is significantly lower for inoperable tumors. Early diagnosis and treatment at specialized centers considerably improve outcomes.

References

Blechacz B. et al. - Cholangiocarcinoma: current knowledge and new developments. Gut and Liver, 2017. Available on PubMed.
European Association for the Study of the Liver (EASL) - Clinical Practice Guidelines on cholangiocarcinoma (2023). Available at easl.eu.
Valle J.W. et al. - Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. New England Journal of Medicine, 2010. Available on PubMed.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category